- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
For this interview, we're joined by Rachael Drake, a pharmacy technician coordinator at the University of Kansas Health System. She works with the medication assistance team, helping uninsured and underinsured patients access drug manufacturer assistance programs and foundation support to cover the costs of their cancer treatments. Drake shares the significant challenges patients face when managing their non-Hodgkin lymphoma treatments, from navigating insurance coverage to affording the high costs of care. She explains how her team collaborates with insurance companies, pharmacists, nurses, and other providers to help patients get the coverage and financial assistance they need.
Drake also highlights the various support systems and resources available, from transportation and lodging assistance to survivorship programs and support groups. However, she notes that many patients are unaware these programs exist, emphasizing the importance of raising awareness to support patients throughout their treatment journey.
This episode of Managed Care Cast is part of the Frameworks for Advancing Health Equity podcast series from The American Journal of Managed Care® Center on Health Equity and Access, setting the stage for a deep dive into program initiatives across the US dedicated to mitigating health care disparities by closing the accessibility gap.
FDA Grants 2 Traditional Approvals for Acalabrutinib
January 17th 2025The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated mantle cell lymphoma (MCL) ineligible for autologous hematopoietic stem cell transplantation and as monotherapy in previously treated MCL.
Read More
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
